
COVID shots should target newer strains of JN.1 variant, US FDA advisers say
By Puyaan Singh and Christy Santhosh (Reuters) - U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period should target newer strains of the JN.1 variant. COVID vaccine makers are seeing increased regulatory scrutiny under the new FDA leadership, facing tighter requirements for their shots that could increase expenses. FDA Commiss ...